CAS Alert: Cease Immediate Use Of Syringe Driver Pumps T34 3 Edition Models

Source: Medicines & Healthcare products Regulatory Agency (MHRA)

Summary

The intended operation of these pumps cannot be verified due to errors in the instructions for use (IFUs) and incompatibility with older versions.

Following the release of the 3rd edition T34 pump, MHRA has received reports of problems associated with using it. This involves, but is not limited to:

  • errors and inconsistencies in the instructions for use
  • incompatibility of the BodyCommTM 88-102 software with 3rd edition pumps
  • changes to battery life
  • use implications due to change in device interface

2nd edition T34 syringe driver pumps (the previous version) are still affected by separate corrective actions addressing the following issues:

  • sunlight protection (MDA/2016/002)
  • battery connection issues (MDA/2019/013)
  • fluid ingress checks (MDA/2019/030)

Actions

  • Identify whether you have any 3rd edition T34 syringe driver pumps (see device details section in the attached CAS alert).
  • Identify patients currently receiving treatment supported by these pumps.
  • Identify all relevant healthcare professionals involved with care delivery using these pumps and advise them to discontinue using the device when clinically appropriate.
  • BD/CME will contact you directly regarding the BodyComm V3.0 software and when the updated version of the IFUs are available.
  • Once you receive the updated IFUs, make sure users are aware of the revised intended use of the pump and other performance specification changes from the previous, 2nd edition, T34 syringe driver pump. BD/CME offers training if required.

Actions by

All technical staff responsible for servicing these devices and healthcare staff who use these pumps.

Deadline for actions

Actions underway: 05 November 2019

Actions complete: 19 November 2019

Click below to view the device details and the full CAS alert:

» Click here to view the full CAS alert

Thank you to Care Uk Knebworth for supplying this image.


CAS Alert: Class 2 Medicines Recall

Summary

M & A Pharmachem is recalling the below batches as a precautionary measure because a small number of pots from some batches have been found to contain discoloured tablets due to fungal contamination. The fungus has been identified as Penicillium citrinum. It is unlikely that any affected tablets will have got to patient level as the discolouration is noticeable on opening affected packs.

 

Batch Number Expiry Date Pack Size First Distributed
0014 04/2022 1 x 1000 28/09/2017
0032 07/2022 1 x 1000 10/10/2017
0033 07/2022 1 x 1000 19/10/2017
0036 07/2022 1 x 1000 02/11/2017
0040 07/2022 1 x 1000 16/11/2017
0041 07/2022 1 x 1000 22/11/2017
0043 07/2022 1 x 1000 28/09/2017
0045 08/2022 1 x 1000 12/12/2017
0046 08/2022 1 x 1000 03/01/2018
0049 08/2022 1 x 1000 24/01/2018
0050 08/2022 1 x 1000 07/02/2018
0053 08/2022 1 x 1000 15/02/2018
0054 08/2022 1 x 1000 23/02/2018
0057 08/2022 1 x 1000 09/03/2018
0060 08/2022 1 x 1000 28/03/2018
0062 09/2022 1 x 1000 13/04/2018
0065 09/2022 1 x 1000 23/04/2018
0067 09/2022 1 x 1000 30/04/2018
0070 09/2022 1 x 1000 30/04/2018
0071 09/2022 1 x 1000 17/05/2018
0073 09/2022 1 x 1000 24/05/2018
0074 09/2022 1 x 1000 07/06/2018
0075 09/2022 1 x 1000 21/06/2018
0078 12/2022 1 x 1000 05/07/2018
0089 12/2022 1 x 1000 23/07/2018
0098 01/2023 1 x 1000 02/08/2018
0100 04/2023 1 x 1000 13/08/2018
0101 04/2023 1 x 1000 17/08/2018
0102 04/2023 1 x 1000 11/09/2018
0105 04/2023 1 x 1000 02/10/2018
0117 04/2023 1 x 1000 12/10/2018
0119 06/2023 1 x 1000 29/10/2018
0123 06/2023 1 x 1000 12/11/2018
0131 07/2023 1 x 1000 23/11/2018
0133 07/2023 1 x 1000 06/12/2018
0140 07/2023 1 x 1000 14/12/2018
0141 07/2023 1 x 1000 20/12/2018
0158 10/2023 1 x 1000 31/01/2018
0159 10/2023 1 x 1000 11/02/2019
0173 10/2023 1 x 1000 22/02/2019

 

Advice for healthcare professionals

Stop supplying the batches listed above immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

 

Action Deadline: Within 48 hours of receiving this CAS alert notification

 

Click below to view the device details and the full CAS alert:

» Click here to view the full CAS alert